Cardiovascular disease is the leading cause of death in Indian women, accounting for roughly 17 to 25 percent of all female deaths each year. That puts it well ahead of breast cancer, cervical cancer, maternal causes, and infectious disease as a cause of premature death. The cultural impression that heart attacks are a male problem and that women die mostly of cancer or in childbirth is decades out of date, and it is one of the most expensive misconceptions in Indian women's health.

Two features make the Indian picture distinct. First, the age curve is shifted earlier. Cardiovascular disease in Indians, men and women, starts 5 to 10 years earlier than in Western populations. An Indian woman in her late forties or early fifties presenting with chest discomfort and risk factors is not too young for it to be cardiac, even if her Western-textbook trained doctor was taught otherwise. Second, the protection that premenopausal oestrogen provides — which lasts until around the late forties in Western women — is shorter and shallower in Indian women because of higher rates of diabetes, central obesity, family history, and earlier menopause.

Third, and most painfully, Indian women reach hospital later than Indian men once a heart attack begins. The average delay is 30 to 60 minutes longer. Some of this is symptom atypicality — the chest pain may be milder or absent. Some of it is self-dismissal: it's just gas, it's just stress, I don't want to bother anyone. Some of it is family or primary doctor reassurance based on the wrong mental model. The cost of delay is measured in heart muscle. A heart attack treated within 90 minutes of door-to-balloon has a dramatically better outcome than one treated after three or four hours, and that single number is where Indian women lose the most ground.

• The symptom textbook is male. Most cardiology training, from medical school onwards, teaches the classic crushing substernal chest pain radiating to the left arm, with sweating and nausea. That picture is real and common in men, but it is the exception rather than the rule in women, where a meaningful share of heart attacks present with jaw, neck, back, or shoulder pain, shortness of breath, nausea, indigestion-like discomfort, lightheadedness, or days of unusual fatigue without classical chest pain at all.
• Women are more likely to be dismissed. Studies from India and globally show that women presenting with chest discomfort to emergency departments are more likely to be sent home with reassurance, told their symptoms are anxiety or gastritis, and to have their cardiac workup delayed compared to men with similar presentations. This is not always conscious bias; it is the operation of the wrong mental model.
• Standard tests can miss women's disease. The treadmill stress test (TMT) has lower sensitivity in women than in men because of smaller arteries, hormonal effects on the resting ECG, and the higher rate of microvascular and vasospastic disease that does not produce the classic obstructive flow-limiting picture. A normal TMT is genuinely less reassuring in a woman with ongoing symptoms than in a man, which is why stress ECHO, stress nuclear scan, or coronary CT or angiography is often the better next step.
• Women self-dismiss for cultural reasons. The deeply held idea that a heart attack is a man's problem, the worry about bothering family, the habit of putting everyone else first, and the tendency to attribute symptoms to gas or anxiety all push women to wait longer before calling 108 or going to the hospital. The data on the 30 to 60 minute extra delay is consistent across many Indian and international studies.
• Microvascular and Takotsubo disease — where Indian women are over-represented — do not always show up on a coronary angiogram. A clean angiogram does not always rule out cardiac disease in a symptomatic woman, and a thoughtful cardiologist will not stop the investigation there if the symptoms are persistent.

• A history of preeclampsia, eclampsia, or HELLP syndrome in any pregnancy raises lifetime cardiovascular risk three to four-fold. This is now firm evidence and is one of the most under-used pieces of cardiac history in Indian women's care. Every woman who has had preeclampsia should have annual BP and cholesterol screening for life, starting earlier and going harder than the general guideline. See preeclampsia-pregnancy-bp-india for the detail.
• Gestational diabetes during any pregnancy raises the risk of later type 2 diabetes two to three-fold and through it raises cardiovascular risk significantly. Annual diabetes screening (HbA1c) is the minimum after GDM. See Gestational Diabetes in India: OGTT Screening, Indian Diet Plan and Safe Management.
• Polycystic ovary syndrome (PCOS) is associated with insulin resistance, central obesity, abnormal lipids, and a higher long-term cardiovascular risk profile. PCOS is not just a fertility problem — it is a lifelong metabolic and cardiac signal. See PCOS Isn’t Your Fault: Understanding, Managing & Thriving.
• Early menopause (before 45) or premature ovarian insufficiency (before 40) shortens the protective oestrogen window and raises cardiovascular risk. Women in this category benefit from earlier and more aggressive risk-factor management and a clear conversation about menopausal hormone therapy options. See What Is Perimenopause? Navigating the Transition with Confidence and Hormone Therapy – Facts in Indian Context.
• Combined hormonal contraception (the pill) in a woman who also smokes, especially over the age of 35, significantly raises the risk of heart attack and stroke. The contraception itself is generally low-risk in non-smokers; smoking is the multiplier.
• Menopausal hormone therapy (MHT or HRT) has a nuanced cardiac story. Started in early menopause for symptom control it does not appear to raise cardiac risk and may be neutral or modestly protective; started late or in older women it can raise risk. Timing matters.
• Autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis raise cardiovascular risk two to three-fold through chronic inflammation. Women with these diagnoses need more aggressive cardiac surveillance than the general population.
• Depression and chronic anxiety raise cardiovascular risk both directly (through chronic stress hormone effects on inflammation, BP, and rhythm) and indirectly (through smoking, sedentary behaviour, and weight). Mental health care is cardiac care.

• Smoking — including bidi, cigarette, hookah, and significant second-hand exposure — is the single most powerful modifiable cardiac risk factor in Indian women. The risk drops sharply within months of quitting and continues to fall for years.
• High blood pressure (over 140 over 90, and ideally over 130 over 80 in higher-risk women) is one of the strongest drivers of stroke and heart disease and is silently common in Indian women in their forties and fifties.
• High LDL cholesterol and abnormal lipid profile, often with low HDL and high triglycerides in Indian women, contribute to atherosclerosis. The Indian dietary pattern (high refined carbs, deep-fried foods, ghee-heavy preparations) is part of why this is so common.
• Diabetes mellitus is a particularly powerful cardiac risk factor in women. A woman with diabetes loses much of the gender protection against heart disease that non-diabetic women have, and cardiac mortality risk rises sharply.
• Central obesity matters more in Indians than overall BMI. A waist circumference over 80 cm in an Indian woman is a meaningful cardiac risk signal even at a normal BMI, because South Asians have a higher proportion of metabolically active visceral fat at any given weight.
• A sedentary lifestyle (less than 150 minutes a week of moderate activity) raises cardiovascular risk substantially. The Indian female pattern of long indoor hours with little structured exercise is part of the problem.
• Family history of premature coronary disease in a first-degree relative (father, brother under 55, or mother, sister under 65) raises personal risk significantly and is one of the most important pieces of history that gets missed in routine consultations.
• Age above 55 in women carries rapidly rising cardiac risk as the menopausal protection wanes, and after 65 the risk approaches that of men of the same age.

• Chest discomfort in women is more often described as pressure, squeeze, tightness, fullness, or heaviness than as sharp pain. Many women never get classic chest pain at all, which is one of the main reasons female heart attacks are missed.
• Pain in the jaw, neck, upper back, between the shoulder blades, in one or both shoulders, or in both arms (not just the left) is much more common in women than the textbook left-arm pattern suggests.
• Sudden shortness of breath, especially without obvious exertion or at rest, is a common female heart attack symptom and is often the only complaint.
• Nausea, vomiting, or indigestion-like discomfort that comes on suddenly, without a dietary trigger, and is accompanied by sweating or breathlessness, should be treated as cardiac until proven otherwise — not as gastritis.
• Cold sweat (sweating that is not heat-related, often with clammy pale skin) is a classical autonomic feature and is reliable in women.
• Lightheadedness, near-fainting, or actual fainting can be the leading feature of a female heart attack, particularly in older women.
• Unusual, profound fatigue that lasts hours to days and is out of proportion to recent activity is reported by many women in the days and weeks leading up to a heart attack. It is one of the most under-recognised warning signs.
• Anxiety with a sense of impending doom, especially combined with any of the above, is a real cardiac symptom and not just anxiety.
• The combination matters most. Any two or three of these together — shortness of breath plus cold sweat plus jaw or back pain, for example — even without classical chest pain, deserves an immediate call to 108 and aspirin chewed (unless allergic or with active bleeding).

Three patterns of cardiac disease are over-represented in women, and Indian women in particular, and all three are easy to miss if the only test done is a coronary angiogram looking for a big blocked artery. Coronary microvascular disease is disease of the tiny coronary vessels that the angiogram cannot see directly. The big arteries can look clean, but the tiny ones supplying the heart muscle can be diseased, constricted, or unable to dilate normally on demand. The patient gets angina-like symptoms with exertion or stress, but the angiogram looks reassuring. Diagnosis often needs cardiac MRI, PET, or specialised invasive flow-reserve testing, and treatment is medical — antianginals, statins, BP control, lifestyle.

Coronary vasospasm (Prinzmetal or variant angina) is sudden constriction of a coronary artery, often at rest, often at night or early morning, sometimes triggered by stress or cold. It causes chest pain that can mimic a heart attack closely. The angiogram between attacks can look normal, and diagnosis often requires either capturing an episode on ECG or a provocation test under controlled conditions. Treatment is calcium channel blockers and nitrates, and avoiding triggers including smoking.

Takotsubo cardiomyopathy — also called broken heart syndrome or stress cardiomyopathy — is a sudden, often profound, weakening of the heart muscle triggered by intense emotional or physical stress (bereavement, accident, surgery, severe argument). It can present exactly like a heart attack with chest pain, breathlessness, and ECG changes, but the angiogram shows clean coronaries and the echocardiogram shows a characteristic ballooning of the apex of the left ventricle. Postmenopausal women are by far the commonest patients, and Indian women are well represented in the Asian Takotsubo literature. Treatment is supportive — most patients recover heart function completely within weeks — but during the acute phase the management is intensive-care level.

• Electrocardiogram (ECG) is the first test in any patient with possible cardiac symptoms. It is fast, painless, costs roughly 100 to 500 rupees, and can show an acute heart attack, an old heart attack, rhythm problems, and signs of strain. A normal ECG does not rule out coronary disease, especially in women — the ECG is most useful during symptoms.
• Echocardiogram (ECHO) uses ultrasound to look at how well the heart muscle is moving, the valves, and the pumping function. It costs roughly 500 to 3,000 rupees and is excellent for detecting old damage, valve disease, Takotsubo's characteristic apical ballooning, and pulmonary pressure changes.
• Treadmill stress test (TMT) measures ECG changes and BP response with exercise. Cost is roughly 500 to 2,500 rupees. It is widely used but has lower sensitivity and specificity in women than in men, and a normal TMT in a symptomatic woman should not be treated as definitively reassuring.
• Stress echocardiogram (stress ECHO) combines exercise or pharmacological stress with echo imaging of wall motion. It is significantly more accurate in women than TMT alone and is the preferred non-invasive test in many female cardiac workups.
• Coronary angiography is the gold standard for seeing the major coronary arteries directly. A catheter is threaded from the wrist or groin to the coronary openings and dye is injected under X-ray. Cost is roughly 15,000 to 50,000 rupees at private centres, much lower at government and PMJAY-empanelled hospitals. It is also the platform for angioplasty if a critical blockage is found.
• Cardiac MRI is the best test for microvascular disease, myocarditis, Takotsubo, infiltrative disease, and detailed function. Cost is roughly 15,000 to 30,000 rupees at private centres.
• Coronary calcium score is a low-dose CT scan that measures calcium in the coronary arteries and is a powerful predictor of future cardiac events, especially in women with borderline risk profiles. Cost is roughly 3,000 to 8,000 rupees.
• Cardiac blood tests include lipid profile (LDL, HDL, triglycerides), HbA1c (for diabetes), high-sensitivity CRP (for inflammation), and BNP or NT-proBNP (for heart failure). Major Indian laboratory networks that run these include Thyrocare, Metropolis, SRL, and Apollo Diagnostics, with troponin (heart attack marker) available at any hospital lab.

• Medical therapy is the foundation for almost every form of coronary disease and is given alongside any procedure. Antiplatelet drugs (aspirin, and after a stent clopidogrel or ticagrelor) reduce clotting on diseased plaques. Statins lower LDL cholesterol and stabilise plaques. ACE inhibitors or ARBs lower BP and protect the heart muscle. Beta-blockers slow the heart, lower BP, and reduce arrhythmia risk. Nitroglycerin (sublingual spray or tablet) relieves angina by dilating coronary arteries.
• Percutaneous coronary intervention (PCI), commonly called angioplasty with stent, is used when a critical narrowing is found. A balloon is inflated in the diseased segment and a drug-eluting stent is left behind to keep it open. Cost in the Indian private sector typically runs 50,000 to 3,00,000 rupees depending on the number of stents, the brand, the hospital, and whether single-vessel or multi-vessel disease is treated. PMJAY covers it at empanelled hospitals.
• Coronary artery bypass grafting (CABG) is open-heart surgery used when there is multi-vessel disease, left main disease, or diabetes with diffuse disease where stents are less durable. Veins from the leg or arteries from the chest or arm are used to bypass the blocked segments. Cost in the private sector typically runs 1.5 to 5 lakh rupees; PMJAY and government cardiac centres are substantially less.
• Primary PCI within 90 minutes of arrival at hospital (door-to-balloon time) is the gold standard for an acute ST-elevation heart attack and is the single biggest determinant of survival and long-term function. This is why getting to a PCI-capable hospital quickly matters more than getting to any hospital. Indian women losing 30 to 60 minutes to delayed recognition is the most expensive deficit in this entire field.
• Thrombolysis (clot-dissolving drugs given intravenously) is used when primary PCI is not available within the time window. It restores flow in many heart attacks but is less effective than PCI and carries a small bleeding risk.
• For microvascular disease, vasospasm, and Takotsubo, treatment is largely medical — calcium channel blockers, long-acting nitrates, statins, ACE inhibitors, beta-blockers (cautiously in vasospasm), and aggressive risk-factor control.

• Ayushman Bharat PMJAY covers angioplasty with stents, CABG, primary PCI for heart attack, and most cardiac diagnostic workup for eligible families up to 5 lakh rupees a year at empanelled hospitals across India. For a heart attack the cashless cover at an empanelled centre is often the single most important financial cushion the family has.
• Government and teaching cardiac centres include AIIMS Delhi and the new AIIMS network, PGIMER Chandigarh, JIPMER Puducherry, Sree Chitra Tirunal Institute Trivandrum, and the cardiology departments of major state medical college hospitals. Quality is generally high and cost is dramatically lower than private; waiting time for planned procedures can be longer.
• Major private heart institutes include Narayana Hrudayalaya (Bangalore) and the Narayana Health network, Fortis Escorts Heart Institute (Delhi), Apollo Hospitals and the Apollo Heart Institute network, Madras Medical Mission (Chennai), Care Hospitals, Asian Heart Institute (Mumbai), Lilavati Hospital (Mumbai), and PD Hinduja Hospital (Mumbai). For a heart attack the closest PCI-capable hospital matters more than the most prestigious one further away.
• For a possible heart attack, do not drive yourself or wait for a private vehicle if 108 ambulance or another emergency service is available — the ambulance gives a head start on ECG, oxygen, aspirin, and pre-notification to the receiving hospital, all of which save heart muscle.
• Comprehensive private health insurance (Star Health, HDFC Ergo, Care, ICICI Lombard, and others) typically covers cardiac procedures including angioplasty and CABG with prior approval; group corporate insurance is usually broader. Read the cardiac sub-limit clauses carefully before assuming everything is covered.
• The National Programme for Prevention and Control of Cancer, Diabetes, CVD and Stroke (NPCDCS) is the public-health scheme that funds population-level cardiac risk screening at primary and community health centres in many districts, and is a good entry point for women without insurance who want a basic BP, blood-sugar, and cholesterol check.

• Healthy weight and waist. Aim for a BMI between 18.5 and 25 and a waist circumference under 80 cm. For Indian women, waist circumference matters more than BMI alone because South Asians carry more visceral fat at any given weight, and central obesity is a stronger cardiac signal.
• 150 minutes a week of moderate aerobic activity (brisk walking, cycling, swimming, dance) split across at least five days, plus two sessions a week of strength work. Daily step counts of 7,000 to 10,000 are a reasonable practical target. Yoga is useful as a stress-management adjunct but is not by itself a substitute for aerobic exercise.
• An Indian-Mediterranean diet — plenty of vegetables, dals and pulses, whole grains (millets, brown rice, jowar, ragi), fish and lean protein, nuts and seeds, fruit, with less refined sugar, less deep-fried food, less ghee-and-cream in routine cooking, and minimal ultra-processed snacks. The traditional South Indian and coastal-Indian patterns score well on cardiac outcomes when followed consistently.
• Quit smoking completely (including bidi, hookah, and significant second-hand exposure) and keep alcohol within modest limits — for women, even small amounts add cardiac and breast cancer risk, and no level of alcohol is cardio-protective in the way some older studies suggested.
• Tight numerical control of the three big risk numbers. Blood pressure below 140 over 90 for the general population and below 130 over 80 for women with diabetes or established cardiac disease. LDL cholesterol below 100 mg/dL for women over 50 and below 70 mg/dL for women with established cardiac disease. HbA1c below 7 percent for most women with diabetes. Regular sleep of 7 to 9 hours and active stress management (therapy, meditation, walking, hobbies, relationships) are not soft extras — they are part of the cardiac prescription.

One of the most important under-used insights in Indian women's cardiac care is that pregnancy is a natural stress test for the cardiovascular system, and several pregnancy diagnoses act as powerful lifetime markers of future cardiac risk. A woman who had preeclampsia, eclampsia, or HELLP syndrome in any pregnancy carries a three to four-fold lifetime risk of cardiovascular disease compared to a woman who had a normotensive pregnancy. This is now firm and consistent evidence, and it changes what her ongoing care should look like.

Every woman who has had preeclampsia or any hypertensive disorder of pregnancy should have annual BP measurement, annual cholesterol and lipid screening, periodic HbA1c, and aggressive risk-factor management throughout her life, starting in the years immediately after the affected pregnancy and continuing without dropping off. She is also a candidate for earlier consideration of statins and BP control. See preeclampsia-pregnancy-bp-india for the pregnancy-side detail.

A woman who had gestational diabetes (GDM) carries a two to three-fold risk of later type 2 diabetes and through that a significantly raised cardiovascular risk. Annual HbA1c (or at minimum a fasting glucose) is the absolute minimum after GDM, and a postpartum oral glucose tolerance test at six to twelve weeks is good practice. See Gestational Diabetes in India: OGTT Screening, Indian Diet Plan and Safe Management.

HELLP syndrome (the severe variant with haemolysis, elevated liver enzymes, and low platelets) carries the highest lifetime cardiac and renal risk and warrants both cardiology and nephrology follow-up over time.

These histories do not need to be a source of fear; they should be a source of action. Knowing them turns prevention from generic advice into a personalised programme that has a real chance of changing the trajectory.

• Myth: heart attacks are mainly a man's problem. Fact: heart disease is the number one cause of death in Indian women, killing more women each year than all cancers combined.
• Myth: a heart attack always presents with crushing left-sided chest pain. Fact: many female heart attacks present without classical chest pain — jaw or back pain, breathlessness, nausea, cold sweat, and unusual fatigue are common female patterns and are too often dismissed.
• Myth: women's heart attacks are less serious than men's. Fact: women have higher in-hospital mortality from heart attack than men, partly because of delayed recognition, delayed presentation, and atypical presentation. The disease is at least as serious; the recognition pathway is what is broken.
• Myth: a normal stress test rules out heart disease. Fact: the standard treadmill stress test has lower sensitivity in women than men, and a normal TMT in a woman with ongoing symptoms is not definitive — stress ECHO, calcium score, or angiography may be needed.
• Myth: a normal angiogram rules out cardiac disease. Fact: microvascular disease, vasospasm, and Takotsubo cardiomyopathy all over-represent in women and can present with cardiac symptoms despite normal-looking large coronary arteries.
• Myth: a daily aspirin prevents heart attacks in every woman. Fact: routine daily aspirin for primary prevention is no longer recommended for everyone; the benefit is modest in low-risk women and the bleeding risk is real. After age 50 with high cardiac risk, or after a confirmed cardiac event, it is generally indicated; the decision should be individualised with a doctor.
• Myth: I exercise and eat well, so I cannot have heart disease in my fifties. Fact: family history, diabetes, hypertension, lipids, smoking, and pregnancy history all matter independently of lifestyle, and a woman with a strong family history of premature cardiac disease can have disease despite a healthy life. Lifestyle reduces risk; it does not eliminate it.
• Myth: it is just gas, just stress, just age, I will rest and see how it feels. Fact: in any woman over 40 with sudden chest, jaw, back, or shoulder discomfort, breathlessness, sweating, or unusual fatigue lasting more than 10 to 15 minutes, the right action is to call 108, chew an aspirin (unless allergic or actively bleeding), and get to a PCI-capable hospital. The cost of a false alarm is a few hours and a few thousand rupees. The cost of a missed heart attack is heart muscle that will not come back.